Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice

Marcello Arca; David Ansell; Maurizio Averna; Francesca Fanelli; Katherine Gorcyca; Şerban R. Iorga; Aldo Maggioni; Georges Paizis; R. Tomic; Alberico L. Catapano

doi:10.1016/j.atherosclerosis.2018.02.024

Related publications

Article2023

Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study

Leonardo De Luca, Pier Luigi Temporelli, Michele Massimo Gulizia, Lucio Gonzini, T Ammaturo, Luigi Tedesco, Silvia Pede, Fabrizio Oliva, Domenico Gabrielli, Furio Colivicchi, Maurizio Averna, Leonardo De Luca, Michele Massimo Gulizia, Pier Luigi Temporelli, Carmine Riccio, Furio Colivicchi, Antonio Francesco Amico, Dario Formigli, Girolamo Geraci, Andrea Di Lenarda, Leonardo De Luca, Aldo Maggioni, Aldo Maggioni, Donata Lucci, Andrea Lorimer, G Orsini, Lucio Gonzini, Gianna Fabbri, P. Priami, Patrizia Maras, Federica Ramani, Colomba Falcone, Ilaria Passarelli, Silvia Mauri, Paolo Calabrò, Renatomaria Bianchi, Gaetano Di Palma, F Mascia, Alfredo Vetrano, Adelaide Fusco, E Proia, Furio Colivicchi, Alessandro Aiello, Fabrizio Tomai, R. Licitra, Alessandro Petrolini, B. Bosco, F Magliari, M Callerame, T Mazzella, G.V. Lettica, Gianluca Lo Coco, F Incao, Lina Marinacci, S D‘Addario, Sara Tartaglione, S. Ubaldi, Federico Ariel Sànchez, Paolo Costa, Giuseppe Manca, Michelle D. Failla, Marino Scherillo, Vincenza Procaccini, Dario Formigli, Michele Senni, E M Luminita, Paolo Bonomo, C Mossa, Stefano Corda, Angela Rita Colavita, G Trevisonno, Giampiero Vizzari, Nicola Cosentino, C Formaro, Claudio Paolillo, I L Nalin, Francesco Mario De Rosa, F Fontana, G.F. Fuscaldo, E. Passamonti, E. Bertella, Elva Calvaruso, Elisabetta Varani, F Tani, Giordano Cicchitelli, Domenico Gabrielli, P Paoloni, Alessandro Marziali, Gianluca Campo, Matteo Tebaldi, Simone Biscaglia, Matteo Di Biase, Natale Daniele Brunetti, Andrea Gallotta, Luisa Mattei, R. Marini, F. Balsemin, Maurizio Urbano, Rita Naio

Article2017

Use of lipid lowering drugs in patients at very high risk of cardiovascular events: An analysis on nearly 3,000,000 Italian subjects of the ARNO Observatory

Aldo Maggioni, Silvia Calabria, Elisa Rossi, Nello Martini

Article2020

Intelligence, educational attainment, and brain structure in those at familial high‐risk for schizophrenia or bipolar disorder

Hilleke E. Hulshoff Pol, Christina M. Hultman, Martin Ingvar, Viktoria Johansson, Erik G. Jönsson, Fergus Kane, Matthew J. Kempton, Marinka M. G. Koenis, Miloslav Kopeček, Bernd Krämer, Stephen M. Lawrie, Rhoshel Lenroot, Machteld Marcelis, Venkata S. Mattay, Colm McDonald, Andreas Meyer‐Lindenberg, Stijn Michielse, Philip B. Mitchell, Dolores Moreno, Robin M. Murray, Benson Mwangi, Leila Nabulsi, Jason Newport,

Article2022

Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study

Martino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, Daniele Andreini, Felicita Andreotti, Ele Ferrannini, Roberto Latini, Aldo Maggioni, Marco Magnoni, Giuseppe Mercuro

Article2021

Healthcare Resource Utilization, Cardiovascular Event Rate and Use of Lipid-Lowering Therapies in Secondary Prevention of ASCVD in Hospitalized Patients in Italy

Paolo Sciattella, Aldo Maggioni, Emanuela Arcangeli, Eduard Sidelnikov, Doreen A. Kahangire, Francesco Saverio Mennini